AzTrials
AzTrials

Impingement Syndrome, ShoulderNCT05607264

Kinesio Taping Technique Versus Virtual Reality in Patients With Chronic Shoulder Impingement Syndrome

A study testing Kinsiotaping and Conventional treatment in people with Impingement Syndrome, Shoulder, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose of the Study: to compare between the effect of kinesio taping technique versus virtual reality technique in rehabilitation of patients with chronic shoulder impingement syndrome. Read more about this study

Who is it for?
Ages 25 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Impingement Syndrome, Shoulder
What is being tested?
Kinsiotaping and Conventional treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteEgypt
Study dates
1 Mar 2021to 1 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 1. Patients will be diagnosed with chronic shoulder impingement syndrome (who had supraspinatus tendinitis stage (II) 2. Ages 25-40 years 3. Both sexes will be included. 4. Patients complaint from limitation in the ROM in abduction flexion and external rotation.
  • 5. Patient complaint from pain and tendinitis in subacromial area more than 3 in VAS.
  • 6. All patients complaint from difficulties in joining ADL activities. 7. All patients will assign written consent form.

Who cannot join

  • Subjects with the following criteria will be excluded from the study:
  • Shoulder fracture or instability.
  • Previous shoulder surgery.
  • Arthritis of the glenohumeral or acromioclavicular joints.
  • Cervical radiculopathy
  • Patients with visual disorders.
Show all 10Show fewer
  • Diabetic patients.
  • Balance and coordination disorders.
  • Tumor and breast cancer.
  • Major trauma.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Outpatient clinic, Faculty of Physical Therapy, Cairo University, Egypt.

    Dokki, 35111

Other trials in Egypt

About this study

Official title: Kinesio Taping Technique Versus Virtual Reality in Rehabilitation of Patients With Chronic Shoulder Impingement Syndrome

Purpose of the Study: to compare between the effect of kinesio taping technique versus virtual reality technique in rehabilitation of patients with chronic shoulder impingement syndrome.

Read the detailed description

Rotator cuff disorders are considered to be among the most common causes of shoulder pain and disability encountered in both primary and secondary care, with subacromial impingement syndrome in particular being the most common disorder, resulting in functional loss and disability, of the shoulder.

There is a lack of literature about virtual reality exergaming in subjects with orthopedic problems.

To reduce UL impairment, new therapeutic approaches, such as constraint-induced movement therapy, robotic arm training, and virtual reality therapy (VRT), have been successfully employed over the last decade.

Kinesio taping is the increasingly popular method for preventing and treating sports injuries. The tape helps to maintain the joint position, increases the proprioceptive awareness, and assists in removal of exudates thereby reducing pain and improves the muscle function.

So as there is lag in literature regarding the best type of treatment for patients with chronic impingement syndrome so this study will be conducted to compare between kinesiotaping and virtual reality and to determine the best treatment for patients with chronic Shoulder Impingement Syndrome (SIS).

Being tested
Kinsiotaping, Motion-controlled VR games, Conventional treatment
Medical subject headings
Shoulder Impingement Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KinsiotapingOther

    Patients received the kinesiotaping over supraspinatus muscle and deltoid muscle, tape will be removed every three days and subjects will return back to the clinic to reapplication of tape again. Patients received the same therapeutic treatment 3 times/ week for four weeks. KT is air permeable and water resistant, allowing it to stay in place for three to five days.

  • Motion-controlled VR gamesOther

    Virtual Rehab utilizes the unique characteristics of Microsoft Kinects motion technology to track and capture the movements of the patients so that patients become immersed in a 3D environment where they interact with the game. Subjects will include in a supervised virtual reality exergaming program for shoulder movements for 4 weeks, 3 days per week and 10 minutes for session.

  • Conventional treatmentOther

    patients received conventional treatment for chronic shoulder impingement syndrome only.

Study groups in NCT05607264
Study groupRoleWhat they receive
KinsiotapingExperimentalpatients who received kinesiotaping plus conventional treatment for chronic shoulder impingement syndrome.
Receives: Other: Kinsiotaping; Other: Conventional treatment
Virtual Reality trainingExperimentalpatients who received VR training plus conventional treatment for chronic shoulder impingement syndrome.
Receives: Other: Motion-controlled VR games; Other: Conventional treatment
conventional treatmentActive comparatorpatients who received conventional treatment for chronic shoulder impingement syndrome only.
Receives: Other: Conventional treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing the change in musculoskeletal disorders of the upper limbs

    Assessment by using Disabilities of the Arm, Shoulder, and Hand Questionnaire (DASH). The DASH is a 30-item self-report questionnaire designed to assess musculoskeletal disorders of the upper limbs. Scoring the DASH 30-item disability/symptom section:

    1. Item responses range from 1 (e.g. no difficulty, not at all, not limited, none, strongly disagree) to 5 (e.g. unable, extremely, unable, strongly agree). Scoring the optional 2 4-item high performance sections: 1) Add values of each response, then divide by 4, subtract 1 and multiply by 25: [((sum of values/4) - 1)*25]. 2) Optional modules should not be scored if items are missing. Arabic version of DASH questionnaire will be used, Which is reliable and valid to be used for evaluating upper extremity work related injuries.

    Measured: at baseline and after 4 weeks of intervention

  2. Assessing the change in pain intensity

    Assessment by using visual analouge scale (VAS). It was used to assess the intensity of pain. Operationally a VAS is usually a horizontal line, l00 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.

    Measured: at baseline and after 4 weeks of intervention

  3. Assessing the change in shoulder range of motion

    Assessment by using Electro goniometer. It was used to measure shoulder ROM (flexion, abduction, internal rotation).

    Measured: at baseline and after 4 weeks of intervention

  4. Assessing the change in muscle activity of Supraspinatus muscle

    Assessment by using Electromyogram (EMG). It was used to measure muscle activity of Supraspinatus, infraspinatus, anterior and middle deltoid.

    Measured: at baseline and after 4 weeks of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2022
  2. Study start1 Mar 2021
  3. Primary completion1 Jan 2022
  4. Study completion1 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05607264
Sponsor's protocol ID
Hend_PhD_2022
Status last verified
Nov 2022
First submitted
1 Nov 2022
Last updated
7 Nov 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Kinsiotaping and Conventional treatment in people with Impingement Syndrome, Shoulder, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing the change in musculoskeletal disorders of the upper limbs (time frame: at baseline and after 4 weeks of intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in